Comparison of insulin glargine vs standard insulin therapy [bedtime insulin suspension isophane] in CFRD [cystic fibrosis-related diabetes] without fasting hyperglycemia.

Trial Profile

Comparison of insulin glargine vs standard insulin therapy [bedtime insulin suspension isophane] in CFRD [cystic fibrosis-related diabetes] without fasting hyperglycemia.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Dec 2009

At a glance

  • Drugs Insulin glargine; Insulin suspension isophane
  • Indications Diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Aug 2007 The expected completion date for this trial is now 1 Aug 2005.
    • 19 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top